Pharmacology, Toxicology and Pharmaceutical Science
Multiple Myeloma
100%
Mantle Cell Lymphoma
100%
RNA-Sequencing
100%
Formaldehyde
50%
Chronic Lymphatic Leukemia
50%
Diseases
50%
Diffuse Large B Cell Lymphoma
50%
Carcinogenesis
50%
Malignant Neoplasm
50%
Lymphosarcoma
50%
Burkitt's Lymphoma
50%
Biological Marker
50%
Follicular Lymphoma
50%
Keyphrases
Circular RNA
100%
B-cell Malignancies
100%
RNA Molecules
100%
Enzyme-free
100%
Exon
13%
IKZF3
13%
Back-splicing
13%
Mantle Cell Lymphoma
13%
Specific Expression
6%
Chronic Lymphocytic Leukemia
6%
3' End
6%
Event Linking
6%
High-throughput RNA Sequencing
6%
In Cancer
6%
5′-end
6%
Disease-specific
6%
Cell Current
6%
Follicular Lymphoma
6%
RNA-sequencing Data
6%
Formalin-fixed Paraffin-embedded Tissue
6%
Expression Profile
6%
Oncogenesis
6%
High-quality Data
6%
Diffuse Large B-cell Lymphoma (DLBCL)
6%
Myeloma Cells
6%
Expression Pattern
6%
Patient Samples
6%
Enzymatic Reaction
6%
Burkitt Lymphoma
6%
Degraded RNA
6%
Prognostic Biomarker
6%
Diagnostic Biomarker
6%
Regulatory Function
6%
Multiple Myeloma
6%
Wide Landscape
6%
Endogenous Substances
6%
Medicine and Dentistry
B Cell
100%
Cancer
100%
RNA Sequence
33%
Mantle Cell Lymphoma
33%
Exon
33%
B-Cell Chronic Lymphocytic Leukemia
16%
Biological Marker
16%
Follicular Lymphoma
16%
Cell Line
16%
Burkitt's Lymphoma
16%
Diseases
16%
Diffuse Large B-Cell Lymphoma
16%
Malignant Neoplasm
16%
Diagnosis
16%
Carcinogenesis
16%
Lymphosarcoma
16%
Formaldehyde
16%
Multiple Myeloma
16%
Biochemistry, Genetics and Molecular Biology
Enzyme
100%
B Cell
100%
Circular RNA
100%
Exon
33%
IKZF3
33%
Deep Sequencing
16%
RNA Sequence
16%
RNA
16%
Carcinogenesis
16%
Immunology and Microbiology
B Cell
100%
Lymphoma Cell
33%
RNA Sequence
33%
Exon
33%
Prognostic Biomarker
16%
Multiple Myeloma
16%
Cell Line
16%